依托诺雌酚
医学
左炔诺孕酮
专家意见
避孕植入物
妇科
地塞米松
计划生育
植入
人口
产科
牙科
重症监护医学
外科
研究方法
环境卫生
作者
Giovanni Grandi,Lia Feliciello,Alice Sgandurra,V. Pedrini,Gloria Guariglia,Valentina Ferrari,Nicoletta Del Duca,Antonio La Marca
标识
DOI:10.1080/13625187.2024.2434846
摘要
The use of long-acting reversible contraceptives (LARCs) is increasing globally due to their higher ability to effectively prevent unintended pregnancies in comparison to short-acting reversible contraceptives (SARCs), especially in adolescence. LARCs include intrauterine devices (copper- or levonorgestrel-releasing) and subcutaneous implants. For LARCs application a dedicated training is needed. Particularly, this Expert Opinion is aiming to open to expert debates on the subcutaneous implant, in particular etonogestrel (ENG)-releasing one, as a cutting-edge form of hormonal contraception. It provides up-to-date guidance about practical advice and technical tips for the ENG implant insertion/removal derived from many years of clinical experience, along with recommendations for the management of unscheduled bleeding during contraception with this method.
科研通智能强力驱动
Strongly Powered by AbleSci AI